OR WAIT null SECS
Peter Urbanowicz, managing director and co-head of Alvarez and Marsal’s Healthcare Industry Group, discusses the FDA’s new focus in addressing supply chain and device shortages posed by the COVID-19 pandemic and what hospitals should be doing in the meantime to adjust.
On this week's episode of Data Book, Chief Healthcare Executive™ spoke with Peter Urbanowicz, managing director and co-head of Alvarez and Marsal’s Healthcare Industry Group. We discussed the FDA’s recent shift in priorities to address supply chain issues, device shortages, and the backlog of drug approvals as well as how technology can help. We also talked about how hospitals are handling these issues and what they can do as they wait for the FDA to catch up.